Innocan Pharma (INNPF) Net Margin (2024 - 2025)
Innocan Pharma (INNPF) recorded Net Margin of 55.69% in the quarter ended Dec 31, 2025, up 19.00 percentage points from 36.70% a year earlier and up 84.23 percentage points from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) Net Margin (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Innocan Pharma reported Net Margin of -1.28%, down 2.17 percentage points from the prior year.
- Across earlier years, Net Margin came in at 0.89% in the year ended Dec 31, 2024 (-30.21 pp) and 31.10% in the year ended Dec 31, 2023.
- The figure for the quarter ended Dec 31, 2025 is the highest quarterly Net Margin in data going back to the quarter ended Mar 31, 2024.
- On a year-over-year basis, Net Margin rose in two of the last four quarters, with an average year-over-year change of +0.01 percentage points.
- Per Business Quant, the preceding three quarters came in at -28.54% (quarter ended Sep 30, 2025), -8.42% (quarter ended Jun 30, 2025) and -2.94% (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 19.55% |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 55.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 55.69% |
| Sep 30, 2025 | -28.54% |
| Jun 30, 2025 | -8.42% |
| Mar 31, 2025 | -2.94% |
| Dec 31, 2024 | 36.70% |
| Sep 30, 2024 | -3.36% |
| Jun 30, 2024 | 3.90% |
| Mar 31, 2024 | -21.48% |
API Access
Innocan Pharma Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();